CAY10598 – 5 mg

Brand:
Cayman
CAS:
346673-06-1
Storage:
-20
UN-No:
De Minimis - 1170 / 3

Prostaglandin E2 (PGE2) activates four E prostanoid (EP) receptors, EP1-4. EP4 is a Gs protein-coupled receptor that, by elevating the second messenger cAMP, plays important roles in bone formation and resorption, cancer, and atherosclerosis.{16772,16773,16619} CAY10598 is a very potent agonist of EP4, binding with a Ki value of 1.2 nM.{16762} Moreover, it does not bind EP1, EP2, EP3, or other prostanoid receptors, including DP, FP, IP, and TP.{16762} First generation EP4 receptor-selective agonists have been shown to reduce inflammation, improve bone healing, provide cardio- and neuroprotection, and reduce renal dysfunction, suggesting some clinical applications for EP4 agonists.{18099,18101,18100,18103,18102}  

 

SKU: - Category:

Description

A very potent agonist of EP4, binding with a Ki value of 1.2 nM; does not bind EP1, EP2, EP3, DP, FP, IP, or TP receptors


Formal name: 5-[(3S)-3-hydroxy-4-phenyl-1-buten-1-yl]1-[6-(2H-tetrazol-5R-yl)hexyl]-2-pyrrolidinone

Synonyms: 

Molecular weight: 383.5

CAS: 346673-06-1

Purity: ≥98%

Formulation: A solution in ethanol


Product Type|Biochemicals|Receptor Pharmacology|Agonists||Research Area|Lipid Biochemistry|Cyclooxygenase Pathway||Research Area|Neuroscience|Neuroprotection